Orexigen Gets Interim OK For $7.5M DIP To Fund Sale Process
Bankrupt prescription weight-loss treatment maker Orexigen Therapeutics Inc. received interim approval Tuesday in Delaware for access to $7.5 million in debtor-in-possession financing as part of a larger $70 million package....To view the full article, register now.
Already a subscriber? Click here to view full article